Other Articles:

Trust Me, I'm from HR/IT/Legal/Finance

Open Letter to Clients: Why You Should Drop RFPs

Competitive Strategy and Business Legitimacy

Sales Efficiency Can Hurt Your Marketing

How Social Media Are Ruining Your Lead Qualification Strategy

Rebuilding Trust in the Financial Sector

Objections Are Not Your Enemy

Are You Talking Your Way Out of a Sale?

Why Should We Buy from You? Good Question!

Your Competitor Is Your Customer Is Your Partner

Three Strategies to Increase Business's Trust

Three Strategies for Creating Customer Trust

You Can Sell to the Purchasing Agent

Deliver the Perfect Pitch

Sales Lessons for Professionals from the Ballroom Dance

Shut Up and Sell

Metrics: Overmeasuring Our Way to Management

When Customer Focus Becomes Predatory

How to Answer the Toughest Sales Question

Why Value Propositions Are Overrated

What to Say When the Client Says Your Price is Too High

Selling From Principle

Stop Trying to Close and Enjoy the Ride

The Only Two Screening Decisions You Have to Make

Do a Sales Job on Yourself

Wall Street Run Amok: Why Harvard's to Blame

The Paradox of Selling

Does Trust Really Take Time?

Client Focus Right vs. Client Focus Lite

Discounting, Price, Value and Psychology

Client Service, Not Client Servility

Competitive Disadvantage: New Sales Strategies for New Business Models

Some Kinds of Sales Motivation are Better Than Others

Applying Trust Principles to the Sales Process Handout

Trust Process Description Short Form

The Trust Equation: A Primer

The Point of Listening is Not What You Hear, but the Listening Itself

What You Should Say About Your Competition when the Client Asks You

Giving Prospects the Confidence to Hire You

Does Your Customer Trust You? The Acid Test

Write Your Next Proposal Sitting Next to the Client

My Client Is a Jerk: Three Keys to Transforming Relationships Gone Wrong

Don't Handle Objections Like Snakes

Trust in Business: The Core Concepts

Friends, Motives and Profits: Avoid Fear-based Selling

When Clients Don't Buy What a CPA Firm is Selling

Truth, Lies and Unicorns

Don't Let Lead Screening Hurt Your Marketing

Stop Trying to Close the Sale

Sustaining Client Relationships: Commercial Lender As Trusted Advisor

Are You Client-Focused, Or A Client Vulture?

Why Your Sales Process Matters Less Than The Psychology Of Selling

Don’t Treat Clients Like Competitors! The Four Principles Of Trust-Based Selling

Create Trust, Gain a Client

The Business Case For Trust

Banking Relationship Strategies and Fake Trust

Metrics and Trust

Scandals and the Backlash Against Trust

Profitability in Professional Services

Build Trust Into Your Selling

Trust-Based Negotiation

Competing With Your Customers: Where Strategy Goes Wrong

Differentiation Through Selling, Not Branding

When Clients Demand Price Cuts

Dealing With RFPs, Purchasing Agents, and Other Formal Buying Processes

The Relationship is the Customer

What Should Enron Have Taught Us?

The Death of Corporations

Leadership, Trust and Intangible Services

Do Clients Buy the Law Firm, or the Lawyer?

Clients, Values and Guiding Principles

Client Satisfaction Surveys: Yea or Nay?

Features, Benefits and Trust

Selling by Doing, Not Selling by Telling

What Buyers Really want

HR Leaders as Trusted Business Advisors

Selling Professional Services

Conducting the Sales Conversation

Ten Myths About Selling Intangible Services

2005

Metrics and Trust

By Charles H. Green

We have all heard the phrase “if you can’t measure it, you can’t manage it.” Most managers accept it uncritically; many believe it passionately.

Yet it is untrue on the face of it. Worse yet, when it comes to trust, the mania for measurement isn’t just benign—it can be positively trust-destroying. This is true of measuring both the business impact of trust, and of measuring trustworthiness itself. Let’s explore an example to see why; then talk about what can be done.

An Example: Pharmaceutical Reps

In the pharmaceutical business, the key salesperson is the rep, or detailer. His or her job is to visit doctors and hospitals. Their objective, as most firms define it, is to influence the doctor or hospital to prescribe (write script for) the drugs their firm represents. Lacking direct data (reps don’t walk out with an order), the industry is understandably very interested in tracking the effectiveness of reps’ calls on physicians.

The industry has developed sophisticated metrics for tracking and analyzing the effect on physician script-writing of reps’ visits, their message, and the complex incentive pay schemes of the reps. This is seen as critical, since only 8 of 100 rep visits end with the physician meeting the rep and remembering what was said. The industry has deployed tens of thousands of reps; the ratio of pharma reps to doctors in the US is nearly 1 to 1. The average call lasts between 30 seconds and 3 minutes .

Now imagine you’re a physician. Five or more reps per day want your time. They call you a “target.” They have data on prescriptions you write, and want you to write their drug more. You know their compensation is affected by their success in so doing. You know their company has spent millions on figuring out just what kind of reps and what message will influence you the most. You know your responses will be measured and fed into a database; and the next time you see a rep, he or she may ask you why you didn’t take their advice.

In that scenario, how much do you trust the rep?

They see reps as out to increase their firm’s sales, while the physician is focused on patient health. Most physicians feel they must get beneath the hype to figure out the truth.

This is an undeniably tough market. Yet the pharmaceutical industry’s response has been, arguably, exactly wrong. Faced with an indirect sales situation, with very little face time with physicians, and with intense competition for time, the industry’s response has generally been to:


  • Hire more reps
  • Hire younger reps, with high ratings of inter-personal attractiveness
  • Train the reps on message
  • Use sophisticated systems to track the profit impact of all aspects of sales.

This response generates feedback noise. More reps means less time per rep; younger reps means less technical experience; training on message not product means less credibility. Sophisticated systems and marketing focus tell the physician that, as far as the pharma company is concerned, he or she is simply a wallet in a white coat.

The message the physician takes away from such high-powered marketing programs is that the company’s interest in him or her is somewhere between little and none.

The Problem with Measurement

The pharmaceutical industry’s dilemma will get worse until it figures out that measurement and behaviors aren’t the problem—attitudes are. If I as a customer believe that your objective is first, last and foremost to maximize my profitability to you, then I feel no different from a vendor, a supply chain, or a raw material. To you, I am merely an object; an object to be managed, cost-reduced and revenue-enhanced.

In such a case, highly refined measurements of the system’s effectiveness don’t make me feel better—they simply compound the fact that you view me as an object.

Half-measures compound the problem. Pharma is hardly alone in increasingly telling its customers things like “we want your loyalty,” “we want to be your trusted advisor,” or “we are customer-focused.” Meanwhile, they work to ensure that every customer interaction maximizes the impact on the seller’s bottom line.

Metrics on the impersonal side of the business are fine. Customers are glad to see their suppliers reducing supply chain costs, making production more lean and efficient. But human beings don’t like being treated that way.

The problem with measurement isn’t limited to linking customers to profits. It also arises in measuring things like trust directly. I once got a phone call from someone who had developed a 4-page spreadsheet of indicators of trustworthiness. He was proposing to implement them as part of his firm’s core skills set, complete with needs analysis package and skills development program. Central to it all was measuring his organization’s people performance on their trustworthiness.

In other words, he was proposing a system centered on skills measurement, training and rewards for being trustworthy. If I were his client, I would want to ask: how trustworthy can this person be if his trustworthiness depends on how much he gets paid for being trustworthy, and on whether he has taken a trustworthiness skills training course?”

I found it hard to explain to him the problem. After all, he said—“If you can’t measure it, how can you manage it?”

A Better Way

Very simply, the only way to be trusted is to actually be trustworthy. The only way to be trustworthy is to have your customers’ best interests at heart. If you are trustworthy, you will come to be seen as trustworthy. If you are seen as trustworthy, you will become very profitable.

The paradox is—you can’t set out to be profitable by being trustworthy—it destroys the concept. You actually have to care. Profitability is a byproduct.

The acid test of trustworthiness is whether you can ever conceive of recommending a significant competitor’s product to a significant customer. If you cannot ever conceive of it—then either you work for a perfect company or you cannot be trusted. You decide which it is.

You can measure the effect of trust and profitability in the long run—but not the short. The measure of trusted relationships is at the relationship level, not the transaction level. The right measure of customer profitability is at the lifetime, not the quarterly, timeframe.

The most influence comes when you stop trying to influence, and just help. The best measurements come when you stop trying to measure and just do the right thing. The best relationships come from acting from our humanity, not from our spreadsheets.